| 000 | 02852nam a22004335i 4500 | ||
|---|---|---|---|
| 999 |
_c386914 _d386914 |
||
| 001 | 386914 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230205112626.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220927s2022 sz | s |||| 0|eng d | ||
| 020 | _a9783031112843 | ||
| 024 | 7 |
_a10.1007/978-3-031-11284-3 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 |
_aR857.N34 _b2022 EB |
||
| 100 |
_aMukherjee, Sudipto _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9682112 |
||
| 245 | 1 | 0 |
_aNanoparticles in Angiogenesis and Cancer _cby Sudip Mukherjee, Vijay Sagar Madamsetty. |
| 250 | _a1st edition 2022 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2022 |
|
| 300 |
_a1 recurso en línea (VIII, 82 páginas) _b27 ilustraciones, 10 ilustraciones en blanco y negro |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aSynthesis Lectures on Biomedical Engineering _x1930-0336 |
|
| 505 | 0 | _aChapter 1 - Introduction -- Chapter 2 - Current Anti-angiogenic Therapies and their Limitations -- Chapter 3 - Nanomedicine -- Chapter 4 - Organic Nanoparticles in Anti-angiogenic Cancer Therapy -- Chapter 5 - Inorganic Nanoparticles in Anti-angiogenic Cancer Therapy -- Chapter 6 - Potential Challenges in Anti-angiogenic Nanotherapies -- Chapter 7 - Conclusion. | |
| 520 | _aThis book highlights recent developments of organic and inorganic nanomedicine that play a major role in anti-angiogenic cancer therapy. In addition, the authors present examples of nanomedicine based anti-angiogenic agents and their applications in cancer therapy. Angiogenesis is a pathophysiological phenomenon that modulates cell proliferation and cell migration and plays important roles in cancer. Anti-angiogenic nanotherapies have gained immense attention in recent times as alternative cost-effective therapies that opened a new dimension in cancer theranostics. Further the challenges of the anti-angiogenic nanotherapies and possible future perspective are detailed. | ||
| 988 | _aSynthesis Collection of Technology_2022 | ||
| 650 | 7 |
_2embne _9445593 _aNanomedicina |
|
| 650 | 7 |
_2embne _9670510 _aVasos sanguíneos |
|
| 650 | 7 |
_2embne _9174085 _aCáncer _xTratamiento |
|
| 700 | 1 |
_aMadamsetty, Vijay Sagar _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9686595 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783031112836 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031112850 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-11284-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2023 _dz _esc _zSI |
||